BioMaxima S.A., a company listed on the Warsaw Stock Exchange, is a Polish manufacturer of infectious disease diagnostics systems, including microbiology, and antibiotic susceptibility testing (AST), as well as a wide range of in vitro diagnostic reagents and equipment. BioMaxima supplies its products to over 2 thousand laboratories in Poland and exports to more than 60 international markets.